Almac Group announces $5.2m expansion

By Melissa Fassbender

- Last updated on GMT

Almac first established its presence in the US in 1996 with clinical trial operations in Audubon, Pennsylvania. (Image: iStock/tongdang5)
Almac first established its presence in the US in 1996 with clinical trial operations in Audubon, Pennsylvania. (Image: iStock/tongdang5)

Related tags Almac group United states

In conjunction with its 20th year of business in North America, Almac Group has announced a $5.2m investment at its Durham, North Carolina facilities.

Almac currently employs more than 1,600 individuals across six facilities in the US, and expects to create nearly 80 new jobs as part of the expansion.

Update: Almac: investment to ensure space, staff, larger US footprint

The investment will support expansion of the company’s Clinical Services facility as well as the development of its Diagnostics and Clinical Technologies operations. 

As Outsourcing-Pharma.com previously reported​, Almac Group’s Diagnostics Business Unit opened a companion diagnostic development facility earlier this year, giving the company a US base to support further growth.

The facility supports the company’s companion diagnostic (CDx) development partnerships and the downstream delivery of assays for patient testing.

Over the past few years, the company also announced expansions in Asia​ and acquisitions in the UK​ and Ireland​ as well as a new serialization solution​ in April of this year.

Related news

Show more

Related products

show more

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers

Follow us

Products

View more

Webinars